Tissue penetration following orally administered cefuroxime axetil.
Wise
R
R
Department of Medical Microbiology, Dudley Road Hospital, Birmingham, UK.
D000284:Administration, Oral; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use; D001682:Biological Availability; D001768:Blister / Q000378:metabolism; D002440:Cefoxitin / Q000493:pharmacokinetics; D002444:Cefuroxime / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans; D008657:Metabolic Clearance Rate; D012141:Respiratory Tract Infections / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D002440:Cefoxitin; D002444:Cefuroxime; C040738:cefuroxime axetil